Anthropic Enters Drug Discovery Arena with Focus on Neglected Diseases
, , ,

Anthropic Enters Drug Discovery Arena with Focus on Neglected Diseases

Artificial intelligence firm Anthropic has officially launched an internal drug discovery program, signaling a strategic move into the competitive healthcare technology sector. The initiative, unveiled at an event in San Francisco, aims to leverage the company’s advanced AI capabilities to identify treatments for diseases that are often overlooked by traditional biopharmaceutical firms due to perceived […]
New Jersey Representative Tom Kean Reveals 142-Day Absence Was Due to Severe Depression Hospitalization
, ,

New Jersey Representative Tom Kean Reveals 142-Day Absence Was Due to Severe Depression Hospitalization

New Jersey Representative Tom Kean has returned to the House floor after a mysterious 142-day absence, revealing that his prolonged leave was due to clinical depression. Addressing his colleagues on Tuesday, the 57-year-old Republican explained that he was hospitalized to undergo treatment for the condition, which he described as a deeply physical and emotional battle. […]
Medicare Launches Landmark Bridge Program to Cover Obesity Drugs for Seniors
, , ,

Medicare Launches Landmark Bridge Program to Cover Obesity Drugs for Seniors

In a historic shift for federal healthcare benefits, eligible Medicare beneficiaries can now access highly sought-after GLP-1 weight-loss medications for a flat copay of just $50 per month. This unprecedented access is made possible through a newly launched, temporary initiative called the Bridge demonstration program. The rollout marks the first time Medicare is covering medications […]
FDA Launches ‘PreCheck’ Program to Expedite Domestic Drug Manufacturing Facility Reviews
, , ,

FDA Launches ‘PreCheck’ Program to Expedite Domestic Drug Manufacturing Facility Reviews

The U.S. Food and Drug Administration (FDA) has initiated a new pilot program, “PreCheck,” aimed at significantly accelerating the regulatory review process for new pharmaceutical manufacturing facilities within the United States. This initiative seeks to streamline the path for companies to bring new drug production sites online, potentially reducing approval timelines by over a year. […]